193 related articles for article (PubMed ID: 30076029)
1. Neuroendocrine tumors of the small intestine causing a desmoplastic reaction of the mesentery are a more aggressive cohort.
Bösch F; Bruewer K; D'Anastasi M; Ilhan H; Knoesel T; Pratschke S; Thomas M; Rentsch M; Guba M; Werner J; Angele MK
Surgery; 2018 Nov; 164(5):1093-1099. PubMed ID: 30076029
[TBL] [Abstract][Full Text] [Related]
2. Immuno-histochemical correlation of fibrosis-related markers with the desmoplastic reaction of the mesentery in small intestine neuroendocrine neoplasms.
Bösch F; Altendorf-Hofmann A; Koliogiannis V; Ilhan H; Jacob S; Pretzsch E; Nölting S; Werner J; Klauschen F; Auernhammer CJ; Angele MK; Knösel T
J Cancer Res Clin Oncol; 2023 May; 149(5):1895-1903. PubMed ID: 35796776
[TBL] [Abstract][Full Text] [Related]
3. Number, not size, of mesenteric tumor deposits affects prognosis of small intestinal well-differentiated neuroendocrine tumors.
Gonzalez RS; Cates JMM; Shi C
Mod Pathol; 2018 Oct; 31(10):1560-1566. PubMed ID: 29795438
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Factors Associated With Progression for Advanced-Stage/G1 and G2 Small-Bowel Neuroendocrine Tumors After Multimodal Therapy: Experience From a Tertiary Referral Center.
Khetan P; Oyewole F; Wolin E; Kim MK; Divino CM
Pancreas; 2020 Apr; 49(4):509-513. PubMed ID: 32224719
[TBL] [Abstract][Full Text] [Related]
5. Mesenteric Tumor Deposits in Midgut Small Intestinal Neuroendocrine Tumors Are a Stronger Indicator Than Lymph Node Metastasis for Liver Metastasis and Poor Prognosis.
Fata CR; Gonzalez RS; Liu E; Cates JM; Shi C
Am J Surg Pathol; 2017 Jan; 41(1):128-133. PubMed ID: 27684993
[TBL] [Abstract][Full Text] [Related]
6. IMP3 expression in small-intestine neuroendocrine neoplasms: a new predictor of recurrence.
Massironi S; Del Gobbo A; Cavalcoli F; Fiori S; Conte D; Pellegrinelli A; Milione M; Ferrero S
Endocrine; 2017 Nov; 58(2):360-367. PubMed ID: 28210937
[TBL] [Abstract][Full Text] [Related]
7. Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumors.
Shi C; Gonzalez RS; Zhao Z; Koyama T; Cornish TC; Hande KR; Walker R; Sandler M; Berlin J; Liu EH
Am J Clin Pathol; 2015 Mar; 143(3):398-404. PubMed ID: 25696798
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small-Bowel Neuroendocrine Tumors.
Zaidi MY; Lopez-Aguiar AG; Dillhoff M; Beal E; Poultsides G; Makris E; Rocha F; Crown A; Idrees K; Marincola Smith P; Nathan H; Beems M; Abbott D; Barrett JR; Fields RC; Davidson J; Cardona K; Maithel SK
JAMA Surg; 2019 Feb; 154(2):134-140. PubMed ID: 30383112
[TBL] [Abstract][Full Text] [Related]
9. Identification of primary tumors in patients presenting with metastatic gastroenteropancreatic neuroendocrine tumors.
Keck KJ; Maxwell JE; Menda Y; Bellizzi A; Dillon J; O'Dorisio TM; Howe JR
Surgery; 2017 Jan; 161(1):272-279. PubMed ID: 27863780
[TBL] [Abstract][Full Text] [Related]
10. Should mesenteric tumor deposits be included in staging of well-differentiated small intestine neuroendocrine tumors?
Gonzalez RS; Liu EH; Alvarez JR; Ayers GD; Washington MK; Shi C
Mod Pathol; 2014 Sep; 27(9):1288-95. PubMed ID: 24457461
[TBL] [Abstract][Full Text] [Related]
11. Small intestinal neuroendocrine tumors with liver metastases and resection of the primary: Prognostic factors for decision making.
Bertani E; Falconi M; Grana C; Botteri E; Chiappa A; Misitano P; Spada F; Ravizza D; Bazolli B; Fazio N
Int J Surg; 2015 Aug; 20():58-64. PubMed ID: 26074290
[TBL] [Abstract][Full Text] [Related]
12. Mesenteric fibrosis and palliative surgery in small intestinal neuroendocrine tumours.
Blažević A; Zandee WT; Franssen GJH; Hofland J; van Velthuysen MF; Hofland LJ; Feelders RA; de Herder WW
Endocr Relat Cancer; 2018 Mar; 25(3):245-254. PubMed ID: 29255095
[TBL] [Abstract][Full Text] [Related]
13. Role of imaging in the preoperative staging of small bowel neuroendocrine tumors.
Chambers AJ; Pasieka JL; Dixon E; Rorstad O
J Am Coll Surg; 2010 Nov; 211(5):620-7. PubMed ID: 21035044
[TBL] [Abstract][Full Text] [Related]
14. Update on Surgical Management of Small Bowel Neuroendocrine Tumors.
Moris D; Ntanasis-Stathopoulos I; Tsilimigras DI; Vagios S; Karamitros A; Karaolanis G; Griniatsos J; Papalampros A; Papaconstantinou I; Glantzounis GK; Spartalis E; Blazer DG; Felekouras E
Anticancer Res; 2018 Mar; 38(3):1267-1278. PubMed ID: 29491050
[TBL] [Abstract][Full Text] [Related]
15. [Indications and operative procedures for neuroendocrine liver metastases].
Musholt TJ; Lang H
Chirurg; 2009 Feb; 80(2):113-21. PubMed ID: 19212693
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center.
Norlén O; Stålberg P; Öberg K; Eriksson J; Hedberg J; Hessman O; Janson ET; Hellman P; Åkerström G
World J Surg; 2012 Jun; 36(6):1419-31. PubMed ID: 21984144
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Factors Associated with Outcomes in Small Bowel Neuroendocrine Tumors.
Manguso N; Johnson J; Harit A; Nissen N; Mirocha J; Hendifar A; Amersi F
Am Surg; 2017 Oct; 83(10):1174-1178. PubMed ID: 29391119
[TBL] [Abstract][Full Text] [Related]
18. Clinical signs of fibrosis in small intestinal neuroendocrine tumours.
Daskalakis K; Karakatsanis A; Stålberg P; Norlén O; Hellman P
Br J Surg; 2017 Jan; 104(1):69-75. PubMed ID: 27861745
[TBL] [Abstract][Full Text] [Related]
19. Survival outcomes and surgical intervention of small intestinal neuroendocrine tumors: a population based retrospective study.
Wu L; Fu J; Wan L; Pan J; Lai S; Zhong J; Chung DC; Wang L
Oncotarget; 2017 Jan; 8(3):4935-4947. PubMed ID: 27903960
[TBL] [Abstract][Full Text] [Related]
20. Impact of Mesenteric Mass in Patients With Midgut Neuroendocrine Tumors.
Malik P; Pinto C; Naparst MS; Ward SC; Aronson A; Aalberg JJ; Divino CM; Kim MK
Pancreas; 2019; 48(5):682-685. PubMed ID: 31091215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
